PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |chronic hepatitis |
| Sentences | 118 |
| PubMedID- 21196168 | Immunization practices and the use of potent antiviral therapy may have a major impact in reducing the burden of chronic liver disease and the incidence of hepatocellular carcinoma associated with chronic hepatitis b and chronic hepatitis d. |
| PubMedID- 23065464 | Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects. |
| PubMedID- 23564522 | The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown. |
| PubMedID- 25894298 | Aflatoxin levels in chronic hepatitis b patients with cirrhosis or hepatocellular carcinoma in balikesir, turkey. |
| PubMedID- 25788045 | Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment. |
| PubMedID- 25279176 | Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis b virus infection: a field survey between 2000 and 2012. |
| PubMedID- 23860735 | Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21374690 | Previous studies have suggested that prior exposure to hepatitis b virus (hbv) infection may increase the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 23426277 | Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c. |
| PubMedID- 23395693 | Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis c: further evidence in decompensation cirrhosis. |
| PubMedID- 26380927 | The aim of this study was to investigate the feasibility of using serum exosomal micrornas as novel serological biomarkers for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
| PubMedID- 19780938 | Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis b virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. |
| PubMedID- 21332549 | Background and aim: the metabolic factors including obesity, diabetes, and hypertension have been implicated as risk factors of hepatocellular carcinoma (hcc) in patients with chronic hepatitis. |
| PubMedID- 23801839 | Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in taiwan. |
| PubMedID- 22236533 | Similar to ulcerative colitis, 15% of gastrointestinal malignancies arise as a consequence of chronic microbial infections, as demonstrated by the raised chance of hepatocellular carcinoma in patients with chronic hepatitis, association between helycobacter pylori infection and higher gastric cancer risk, and increased chance of colon cancer in patients with inflammatory bowel disease . |
| PubMedID- 20731020 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis. |
| PubMedID- 24409059 | Latent hepatitis b is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 20368541 | This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis b. |
| PubMedID- 24583062 | Background & aims: little is known about whether the antiviral agent entecavir is more effective than a less potent drug, lamivudine, in reducing the risk of death and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b. |
| PubMedID- 23613886 | hepatocellular carcinoma (hcc) resulting from chronic hepatitis b virus (hbv) and/or hepatitis c virus (hcv) infection is an important cause of liver disease worldwide . |
| PubMedID- 24570913 | Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 21331763 | Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 22875473 | Background: we investigated whether the administration of maintenance doses of interferon prevented hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 26070204 | Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response. |
| PubMedID- 24123097 | On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis b receiving entecavir. |
| PubMedID- 24693297 | Transient elastography has also been used to assess the degree of liver fibrosis and the risk of hepatocellular carcinoma development in patients with chronic hepatitis (56, 57). |
| PubMedID- 21526141 | We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 24187458 | Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis b. |
| PubMedID- 23907815 | Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis b. |
| PubMedID- 21319193 | Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 25544880 | Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri. |
| PubMedID- 24619495 | Background: recent studies have shown that high hepatitis b virus (hbv) load is associated with increased risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
| PubMedID- 23781497 | Evaluated the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection and found that the c > t polymorphisms at foki position in the vdr gene served as a potential biomarker for the risk and the disease severity of hcc in those infected with hbv. |
| PubMedID- 23586065 | Aim: to evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection. |
| PubMedID- 22444598 | Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis b infection. |
| PubMedID- 23841664 | Spontaneous clearance of serum hepatitis c virus rna during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21056500 | The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial. |
| PubMedID- 24876745 | Several studies have been carried out to create risk calculators for the prediction of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
| PubMedID- 24055508 | Background & aims: hepatocellular carcinoma develops in patients with chronic hepatitis or cirrhosis via a stepwise accumulation of various genetic alterations. |
| PubMedID- 22972059 | Objectives: to determine the beneficial and harmful effects of alpha-foetoprotein or ultrasound, or both, for screening of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. |
| PubMedID- 23125843 | The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005). |
| PubMedID- 24843320 | Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 20207771 | Results: alpha-fetoprotein (afp) may be used in conjunction with abdominal ultrasound for early detection of hepatocellular carcinoma (hcc) in patients with chronic hepatitis or cirrhosis associated with hepatitis b or c virus infection. |
| PubMedID- 23280722 | Il17a gene polymorphisms, serum il-17a and ige levels, and hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection. |
| PubMedID- 22118340 | The chb natural history influenced density of tumour-infiltrating tregs in hepatocellular carcinoma patients with chronic hepatitis b viruses infection. |
| PubMedID- 26357607 | Data from the long-term follow-up of patients enrolled in the registration studies showed that treatment with entecavir can lead to significant improvements in liver histopathology, and recent cohort studies have demonstrated that treatment with entecavir may reduce disease progression and the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b. |
| PubMedID- 24570914 | Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis b virus infection. |
| PubMedID- 25331666 | Increased risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21910010 | Aim: to compare clinical and radiological findings of newly diagnosed hepatocellular carcinomas (hccs) in patients with chronic hepatitis b virus (hbv) and chronic hepatitis c virus (hcv) infections. |